Motley Fool Premium
  1. Stocks
    2. /
  2. AstraZeneca Plc (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca Plc)

About AZN

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

AstraZeneca Plc (LSE: AZN) Latest News

Investing Articles

Neil Woodford Still Loves Astrazeneca plc And GlaxoSmithKline plc

| Harvey Jones

Neil Woodford's passion for AstraZeneca plc (LON: AZN) and GlaxoSmithKline plc (LON: GSK) is undiminished. Should you share the love?

Read more »

Investing Articles

3 Reasons Why You Should Sell Shire PLC

| Roland Head

Shire PLC (LON:SHP) shareholders should heed the lessons of Pfizer's bid for AstraZeneca plc (LON:AZN), says Roland Head.

Read more »

Investing Articles

3 Growth Shares For Your Nisa: AstraZeneca plc, Diageo plc And Unilever plc

| Rupert Hargreaves

AstraZeneca plc (LON:AZN), Diageo plc (LON:DGE) and Unilever plc (LON:ULVR) look to be three great growth picks for your new…

Read more »

Investing Articles

Should You Invest In Shire PLC Instead Of GlaxoSmithKline plc And AstraZeneca plc?

| Peter Stephens

Is Shire PLC (LON: SHP) now a better investment than GlaxoSmithKline plc (LON: GSK) and AstraZeneca plc (LON: AZN)?

Read more »

Investing Articles

Is AstraZeneca plc’s Latest Director Deal A Game-Changer?

| Peter Stephens

With AstraZeneca plc (LON:AZN)'s CEO buying shares this week, is it a significant event for investors?

Read more »

Investing Articles

Why Shire PLC Could Be A Winning Stock!

| Peter Stephens

Pharmaceutical company Shire PLC (LON: SHP) could be worth buying — here’s why.

Read more »

Investing Articles

One Reason Why I Would Buy AstraZeneca plc Today

| Royston Wild

Royston Wild explains why AstraZeneca plc (LON: AZN) could become a high-profile acquisition target once again.

Read more »

Investing Articles

How Strong Are AstraZeneca plc’s Dividends?

| Alan Oscroft

AstraZeneca plc (LON:AZN) can afford to keep handing out the cash for a couple more years or so.

Read more »

Investing Articles

AstraZeneca plc And Shire PLC Bolster Takeover Defences

| Rupert Hargreaves

Shire PLC (LON: SHP) and AstraZeneca plc (LON: AZN) are working to repel hostile buyers.

Read more »

Investing Articles

One Reason Why I Wouldn’t Buy AstraZeneca plc Today

| Royston Wild

Royston Wild explains why AstraZeneca plc (LON: AZN) is a poor growth selection.

Read more »

Investing Articles

Neil Woodford’s First Buys For His New Fund

| G A Chester

Disclosures by RM2 International SA (LON:RM2), ReNeuron Group Plc (LON:RENE), e-Therapeutics plc (LON:ETX); speculation on AstraZeneca plc (LON:AZN) and BAE…

Read more »

Investing Articles

Why Shire PLC’s Takeover Response Is Highly Unusual

| Peter Stephens

After Abbvie’s £27bn takeover offer was rejected, Shire PLC (LON: SHP) has responded in a rather unusual way...

Read more »